A study of people in Brazil with IDH-mutant diffuse glioma
Official title: A Single-arm Observational Study to Characterize the Epidemiological Profile of Patients With IDH-mutant Diffuse Gliomas Diagnosed From 2021 in Brazil.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study looks back at the health records of people in Brazil who have a brain tumor called IDH gene change: A small change in a tumor's IDH gene. Tumors with this change often grow more slowly and may respond to different treatments. Your pathology report says whether your tumor has it. See the glossary diffuse glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary.
Read our full plain-language summary
What the trial team says
This is a real-world, retrospective, non-interventional, single-arm, multi-center Brazilian study that will include patients diagnosed with IDH-mutant diffuse glioma in Brazil from 2021. Eligible patients will be included in this study to have their medical charts data collected by site personnel. Included patients won´t be requested to attend protocol-specific visits and treatment decisions and disease management will be at the investigator's discretion
Key facts
- Registry number
- NCT07789678
- Conditions studied
- Diffuse Glioma, IDH-mutant Gliomas
Where it is running
This trial lists 12 sites.
-
Estado de Bahia
- IESG Instituto de Ensino da Saúde e Gestão (Salvador)
- Santa Casa de Misericórdia da Bahia - Hospital Santa Izabel (Oncoclínicas) (Salvador)
- ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia (Salvador)
-
Federal District
- OncoStar Rede D'or DF (Brasília)
-
Minas Gerais
- Oncocentro de Minas Gerais (Oncoclínicas) (Belo Horizonte)
-
Rio de Janeiro
- INCA - Instituto Nacional de Câncer (Rio de Janeiro)
- Instituto COI - Clínicas Oncológicas Integradas (Instituto Américas RJ) (Rio de Janeiro)
-
Rio Grande do Sul
- Futtura Oncologia - Hub de Pesquisa Clínica (Porto Alegre)
-
São Paulo
- Hospital Sírio-Libanês SP (São Paulo)
- BP - A Beneficência Portuguesa de São Paulo (São Paulo)
- GRAACC - Grupo de Apoio ao Adolescente e à Criança com Câncer (São Paulo)
- HIAE - Hospital Israelita Albert Einstein (São Paulo)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.